Headlines

Analysts Applaud UiPath’s AI Traction, But Net New ARR Slide Sparks Caution

UiPath reports strong Q1 results, raises FY26 guidance, and sees early success with agentic AI initiatives. Analysts increase price targets.

Latest Ratings for PATH

Date Firm Action From To
Jan 2022 Macquarie Upgrades Neutral Outperform
Jan 2022 Macquarie Upgrades Neutral Outperform
Jan 2022 Oppenheimer Upgrades Perform Outperform

View More Analyst Ratings for PATH

View the Latest Analyst Ratings

read more

Leave a Reply

Your email address will not be published. Required fields are marked *